Estados financieros detallados de Pliant Therapeutics, Inc. (PLRX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $1.07, PLRX presenta beneficios negativos (P/E no significativo) y un ROE del -53.22%. La capitalización bursátil es de $66M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | $57.1M | $41.8M | $7.6M | $9.7M | $1.6M | 0 | 0 |
| Coste de Ventas | 0 | $666000 | 0 | 0 | 0 | 0 | 0 | 0 | $1.7M |
| Beneficio Bruto | 0 | -$666000 | $57.1M | $41.8M | $7.6M | $9.7M | $1.6M | 0 | -$1.7M |
| I+D | $14.5M | $24.4M | $47.4M | $66.2M | $77.5M | $96.9M | $127.8M | $169.3M | $109.2M |
| Generales y Administrativos | $3.8M | $6.5M | $10.9M | $17.3M | $27.6M | $39.9M | $57.9M | $59.1M | $47.2M |
| Gastos Operativos | $18.3M | $30.9M | $58.3M | $83.5M | $105.1M | $136.9M | $185.7M | $228.4M | $148.4M |
| Beneficio Operativo | -$18.3M | -$30.9M | -$1.2M | -$41.6M | -$97.5M | -$127.2M | -$184.1M | -$228.4M | -$150.1M |
| EBITDA | -$18.1M | -$30.2M | -$118000 | -$40.3M | -$95.7M | -$118.8M | -$158.2M | -$205.2M | -$145.1M |
| Gastos por Intereses | 0 | 0 | $216000 | $366000 | 0 | $791000 | $1.3M | $3.0M | $2.6M |
| Beneficio Antes de Impuestos | -$18.3M | -$30.3M | -$631000 | -$41.5M | -$97.3M | -$123.3M | -$161.3M | -$210.3M | -$149.3M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$20.6M | -$30.3M | -$631000 | -$41.5M | -$97.3M | -$123.3M | -$161.3M | -$210.3M | -$149.3M |
| BPA | $-25.67 | $-1.83 | $-0.19 | $-1.17 | $-2.71 | $-2.94 | $-2.75 | $-3.47 | $-2.43 |
| BPA Diluido | $-25.67 | $-1.83 | $-0.19 | $-1.17 | $-2.71 | $-2.94 | $-2.75 | $-3.47 | $-2.43 |
| Acciones en Circulación (Diluidas) | $803497 | $16.5M | $35.6M | $35.6M | $35.8M | $42.0M | $58.7M | $60.5M | $61.4M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | -$264000 | 0 |
| Beneficio Operativo | -$28.3M | -$23.6M | -$21.8M | -$23.9M |
| EBITDA | -$23.1M | -$23.1M | -$19.8M | -$22.2M |
| Beneficio Neto | -$26.3M | -$23.6M | -$20.0M | -$22.4M |
| BPA | $-0.43 | $-0.38 | $-0.32 | $-0.36 |
| BPA Diluido | $-0.43 | $-0.38 | $-0.32 | $-0.36 |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $4.3M | $60.9M | $85.8M | $50.9M | $51.7M | $33.7M | $63.2M | $71.2M | $45.4M |
| Inversiones a Corto | 0 | 0 | $17.0M | $226.0M | $148.9M | $297.5M | $431.0M | $284.5M | $145.5M |
| Cuentas por Cobrar | 0 | $500000 | $7.4M | $9.4M | $2.5M | $3.1M | $3.0M | $2.3M | $823000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $4.7M | $61.7M | $111.9M | $290.8M | $209.4M | $340.3M | $505.5M | $362.3M | $196.4M |
| Inmovilizado Material | $1.8M | $4.3M | $4.1M | $4.3M | $10.9M | $9.9M | $4.8M | $32.8M | $25.0M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $6.6M | $66.5M | $119.1M | $295.5M | $221.2M | $350.6M | $512.2M | $396.9M | $225.2M |
| Cuentas por Pagar | $1.6M | $2.6M | $1.2M | $2.0M | $3.0M | $1.6M | $4.5M | $6.0M | $480000 |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $3.2M | $5.1M | $8.2M | $11.6M | $16.8M | $23.9M | $28.5M | $33.2M | $16.4M |
| Deuda a Largo | 0 | $525000 | 0 | 0 | 0 | $9.9M | $10.1M | $30.2M | 0 |
| Pasivos Totales | $3.2M | $67.4M | $119.5M | $12.5M | $22.2M | $37.3M | $38.6M | $92.9M | $44.0M |
| Reservas | -$36.6M | -$71.5M | -$76.3M | -$117.8M | -$215.1M | -$338.4M | -$499.7M | -$710.1M | -$859.4M |
| Patrimonio Neto | $3.3M | -$882000 | -$435000 | $283.1M | $199.1M | $313.3M | $473.6M | $304.1M | $181.2M |
| Deuda Total | 0 | $525000 | $444000 | 0 | $7.2M | $15.8M | $11.4M | $60.2M | $29.1M |
| Deuda Neta | -$4.3M | -$60.4M | -$102.3M | -$276.9M | -$193.4M | -$315.4M | -$482.9M | -$295.5M | -$161.8M |
| Capital Circulante | $1.5M | $56.6M | $103.7M | $279.2M | $192.6M | $316.4M | $477.0M | $329.0M | $180.1M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $93.7M | $45.4M | $22.2M | $24.9M |
| Activos Totales | $276.6M | $225.2M | $202.6M | $189.9M |
| Pasivos Totales | $76.3M | $44.0M | $37.4M | $43.0M |
| Patrimonio Neto | $200.3M | $181.2M | $165.2M | $146.9M |
| Deuda Total | $59.9M | $29.1M | $28.8M | $28.7M |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$18.3M | -$30.3M | -$631000 | -$41.5M | -$97.3M | -$123.3M | -$161.3M | -$210.3M | -$149.3M |
| Amortizaciones | $292000 | $666000 | $1.1M | $1.3M | $1.5M | $1.8M | $1.8M | $2.1M | $1.7M |
| Compensación en Acciones | $33000 | $228000 | $1.8M | $3.9M | $10.4M | $22.6M | $44.5M | $37.6M | $26.2M |
| Cambio en Capital Circulante | $893000 | $1.1M | -$5.1M | -$1.2M | $6.9M | $4.2M | $1.3M | $9.1M | -$15.9M |
| Flujo de Caja Operativo | -$16.9M | -$28.3M | -$2.8M | -$37.3M | -$75.4M | -$94.6M | -$116.4M | -$155.5M | -$128.3M |
| Inversiones (CapEx) | -$1.4M | -$2.3M | -$964000 | -$1.5M | -$2.0M | -$1.8M | -$921000 | -$3.8M | -$374000 |
| Adquisiciones | 0 | 0 | $254000 | $209.3M | -$75.7M | $148.4M | 0 | 0 | $155000 |
| Recompra de Acciones | -$12000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$18.3M | -$30.7M | -$3.7M | -$38.8M | -$77.4M | -$96.4M | -$117.3M | -$159.4M | -$128.7M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$21.1M | -$17.8M | -$19.2M | -$12.8M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$21.1M | -$17.8M | -$19.2M | -$12.8M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $6.4M | $4.5M | $4.3M | $4.2M |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | | -26.7% | -81.9% | +27.9% | -83.7% | -100.0% | |
| Crecimiento Beneficio Neto (anual) | | -46.8% | +97.9% | -6482.1% | -134.2% | -26.8% | -30.8% | -30.4% | +29.0% |
| Crecimiento BPA (anual) | | +92.9% | +89.6% | -515.8% | -131.6% | -8.5% | +6.5% | -26.2% | +30.0% |
| Cambio en Acciones (anual) | | +1954.8% | +115.3% | +0.0% | +0.8% | +17.2% | +39.8% | +3.1% | +1.4% |
| Crecimiento FCF (anual) | | -67.2% | +87.9% | -944.8% | -99.5% | -24.5% | -21.7% | -35.9% | +19.2% |
| Margen Bruto | | | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | | |
| Margen Operativo | | | -2.2% | -99.6% | -1288.1% | -1313.4% | -11654.7% | | |
| Margen EBITDA | | | -0.2% | -96.5% | -1264.2% | -1227.1% | -10014.4% | | |
| Margen Neto | | | -1.1% | -99.3% | -1284.5% | -1273.3% | -10211.1% | | |
| Margen FCF | | | -6.5% | -92.8% | -1022.1% | -995.3% | -7422.9% | | |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-22.81 | $-1.86 | $-0.10 | $-1.09 | $-2.16 | $-2.29 | $-2.00 | $-2.63 | $-2.10 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $803497 | $16.5M | $35.6M | $35.6M | $35.8M | $42.0M | $58.7M | $60.5M | $61.4M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -53.22% |
| Rentabilidad sobre capital invertido | -55.49% |
| Rentabilidad sobre activos | -48.60% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.20 |
| Ratio corriente | 9.90 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -0.83 | -11.64 | -112.11 | -19.42 | -4.98 | -6.57 | -6.59 | -3.80 | -0.50 |
| P/VC | 5.12 | -398.71 | -1740.79 | 2.85 | 2.43 | 2.59 | 2.25 | 2.62 | 0.41 |
| P/V | 0.00 | 0.00 | 13.27 | 19.32 | 63.91 | 83.86 | 673.04 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | -2.2% | -99.6% | -1288.1% | -1313.4% | -11654.7% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | -1.1% | -99.3% | -1284.5% | -1273.3% | -10211.1% | 0.0% | 0.0% |